Publications by authors named "Maria Rovira-Rigau"

Claim this Profile
P
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.
Raquel Ortiz, Ana Barajas, Anna Pons-Grífols, Benjamin Trinité, Ferran Tarrés-Freixas, Maria Rovira-Rigau

Viruses· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses.
Pau Brugada-Vilà, Anna Cascante, Miguel Ángel Lázaro, Cristina Castells-Sala, Cristina Fornaguera, Maria Rovira-Rigau

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
Giulia Raimondi, Ana Mato-Berciano, Silvia Pascual-Sabater, Maria Rovira-Rigau, Miriam Cuatrecasas

EBioMedicine· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics.
Elena Vila-Navarro, Elena Fernandez-Castañer, Maria Rovira-Rigau, Giulia Raimondi, Maria Vila-Casadesus

Oncogenesis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.
Maria Rovira-Rigau, Giulia Raimondi, Miguel Ángel Marín, Meritxell Gironella, Ramon Alemany

Mol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zeb1 in Stromal Myofibroblasts Promotes -Driven Development of Pancreatic Cancer.
Irene Sangrador, Xavier Molero, Fiona Campbell, Sebastià Franch-Expósito, Maria Rovira-Rigau

Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of MicroRNAs in Oncolytic Virotherapy.
Xavier Bofill-De Ros, Maria Rovira-Rigau, Cristina Fillat

Front Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies.
Eneko Villanueva, Pilar Navarro, Maria Rovira-Rigau, Annarita Sibilio, Raúl Méndez

Nat Commun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic fiber modification to achieve matrix-metalloprotease-activated infectivity of oncolytic adenovirus.
Anabel José, Maria Rovira-Rigau, Jeroni Luna, Marta Giménez-Alejandre, Eva Vaquero

J Control Release· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis